As a pediatric obesity medicine specialist, I have witnessed first-hand the benefits of GLP-1 receptor agonists in the ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is ...

Researchers assess the role of liraglutide in regulating iron metabolism in a mouse model of hereditary hemochromatosis.

Semaglutide vs liraglutide treatment demonstrated superior weight loss at 1 year and 10% weight loss achievement among patients with obesity.

By Hugo Francisco de Souza New research reveals that liraglutide, a GLP-1 receptor agonist, crosses the blood-brain barrier ...

The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Liraglutide was not originally developed as a weight-loss treatment. Like semaglutide (Ozempic), it originally treated ...

The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Patents for Victoza and Saxenda have now expried. So other drug companies are working to develop “generic” versions.

Study reveals liraglutide's potential to regulate iron metabolism and improve glucose tolerance in a mouse model of hereditary hemochromatosis and obesity. Study: Liraglutide Impacts Iron ...

Patients with obesity or type 2 diabetes (T2D) who stuck with their medication for a year lost more weight with semaglutide than with liraglutide, a new study reported. Researchers at the ...